首页> 美国卫生研究院文献>3 Biotech >Over-expression purification and isotopic labeling of a tag-less human glucose-dependent insulinotropic polypeptide (hGIP)
【2h】

Over-expression purification and isotopic labeling of a tag-less human glucose-dependent insulinotropic polypeptide (hGIP)

机译:无标签人葡萄糖依赖性促胰岛素多肽(hGIP)的过表达纯化和同位素标记

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glucose-dependent insulinotropic polypeptide (GIP), a gut peptide released in response to food intake brings about secretion of insulin in a glucose-dependent manner upon binding to its receptor, GIPR. GIP–GIPR has emerged as a new vista for anti-diabetic drug discovery and their interaction is being probed at the atomic level to aid rational drug design. In order to probe this interaction on cells, the current study attempts towards expressing 15N-labeled GIP using classical molecular biology tools. We have developed a methodology to obtain GIP devoid of extra amino acid(s); a prerequisite to the intended interaction study. The synthetic GIP cDNA with a Factor Xa protease site at the N-terminus of GIP was inserted in the vector pET32a(+); the fusion protein thus expressed was eventually cleaved to obtain GIP. After successful Factor Xa cleavage, the cleaved GIP was confirmed by western blot. Subsequently, the (15N)GIP was obtained using the aforementioned procedure and confirmed by MALDI-TOF.
机译:葡萄糖依赖性促胰岛素多肽(GIP)是一种响应食物摄入而释放的肠肽,与受体GIPR结合后会以葡萄糖依赖性方式分泌胰岛素。 GIP–GIPR已成为抗糖尿病药物发现的新视野,并且正在原子级探究它们之间的相互作用以辅助合理的药物设计。为了探究细胞上的这种相互作用,当前的研究尝试使用经典的分子生物学工具表达 15 N标记的GIP。我们已经开发出一种方法来获得不含额外氨基酸的GIP。预期的交互研究的前提。将在GIP N末端具有Xa因子蛋白酶位点的合成GIP cDNA插入载体pET32a(+)中;如此表达的融合蛋白最终被切割以获得GIP。在因子Xa成功切割后,通过蛋白质印迹证实切割的GIP。随后,使用上述程序获得( 15 N)GIP,并通过MALDI-TOF进行确认。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号